Liisa Volin

Liisa Volin

UNVERIFIED PROFILE

Are you Liisa Volin?   Register this Author

Register author
Liisa Volin

Liisa Volin

Publications by authors named "Liisa Volin"

Are you Liisa Volin?   Register this Author

90Publications

3623Reads

45Profile Views

Incidence and risk factors of secondary cancers after allogeneic stem cell transplantation: analysis of a single centre cohort with a long follow-up.

Bone Marrow Transplant 2019 02 13;54(2):334-337. Epub 2018 Aug 13.

Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center and Helsinki University, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-018-0290-6DOI Listing
February 2019

Extracorporeal photopheresis in the treatment of acute graft-versus-host disease: a single-center experience.

Transfusion 2018 08 29;58(8):1973-1979. Epub 2018 Apr 29.

Department of Hematology, Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/trf.14649
Publisher Site
http://dx.doi.org/10.1111/trf.14649DOI Listing
August 2018

A randomized study of cyclosporine and methotrexate with or without methylprednisolone for the prevention of graft-versus-host disease: Improved long-term survival with triple prophylaxis.

Cancer 2018 02 7;124(4):727-733. Epub 2017 Nov 7.

Stem Cell Transplantation Unit, Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31100DOI Listing
February 2018

Unrelated matched versus autologous transplantation in adult patients with good and intermediate risk acute myelogenous leukemia in first molecular remission.

Am J Hematol 2017 Dec 28;92(12):1318-1323. Epub 2017 Sep 28.

Department of Hematology and Cell Therapy and EBMT Paris Office, Hôpital Saint-Antoine APHP, INSERM U 938, Université Pierre et Marie Curie UPMC, Paris, France.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.24904
Publisher Site
http://dx.doi.org/10.1002/ajh.24904DOI Listing
December 2017

Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Cancer 2017 Jul 22;123(14):2671-2679. Epub 2017 Mar 22.

Acute Leukemia Working Party, European Society for Blood and Marrow Transplantation Paris Study Office/European Center for Biostatistical and Epidemiological Evaluation in Hematopoietic Cell Therapy (CEREST-TC), Paris, France.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.30646
Publisher Site
http://dx.doi.org/10.1002/cncr.30646DOI Listing
July 2017

Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial).

J Clin Oncol 2017 Jul 2;35(19):2157-2164. Epub 2017 May 2.

Nicolaus Kröger, University Medical Center Hamburg-Eppendorf, Hamburg; Georg-Nikolaus Franke, University Hospital Leipzig, Leipzig; Uwe Platzbecker, University Hospital Dresden, Dresden; Kai Hübel and Christof Scheid, University of Cologne, Cologne; Thomas Weber, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle; Matthias Stelljes, University of Münster, Münster; Peter Dreger, University of Heidelberg, Heidelberg; Andreas Günther, University Hospital Schleswig Holstein Campus Kiel, Kiel; Wolfgang Bethge, University Hospital Tübingen, Tübingen; Guido Kobbe, Heinrich Heine University, Düsseldorf, Germany; Simona Iacobelli, Università Tor Vergata, Rome; Giorgio Lambertenghi Deliliers and Francesco Onida, Fondazione IRCC Ca' Granda Ospedale Maggiore Policlinico, University of Milano, Milan; Massimo Pini, Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria; Stefano Guidi, Azienda Ospedaliera Universitaria Careggi, Florence, Italy; Ruzena Uddin, Guy's Hospital, London, United Kingdom; Marie Robin, Hôpital Saint Louis, Assistance Publique Hôpitaux Paris, France; Boris Afanasyev, SPB Pavlov Medical University, St Petersburg, Russia; Dominik Heim, University Hospital Basel, Basel Switzerland; Liisa Volin, Helsinki University Hospital, Helsiniki, Finland; Xavier Poiré, Cliniques Universitaires St-Luc, Brussels, Belgium; Marleen van Os, European Group of Blood and Marrow Transplantation Clinical Trials Office; Ronald Brand, Leiden University Medical Center, Leiden; and Theo de Witte, Radboud University Medical Center, Nijmegen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.7349DOI Listing
July 2017

Allogeneic Haematopoietic Stem Cell Transplantation for Patients with Cutaneous T-cell Lymphoma.

Acta Derm Venereol 2016 08;96(6):816-7

Department of Dermatology, Center of Inflammation, Skin and Allergy Hospital, FIN-00250 Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2340/00015555-2362DOI Listing
August 2016

Outcomes after use of two standard ablative regimens in patients with refractory acute myeloid leukaemia: a retrospective, multicentre, registry analysis.

Lancet Haematol 2015 Sep 24;2(9):e384-92. Epub 2015 Aug 24.

European Group for Blood and Marrow Transplantation (EBMT) Paris Study Office/CEREST-TC, Paris, France; Department of Haematology, Saint Antoine Hospital, Paris, France; INSERM UMR 938, Paris, France; Université Pierre et Marie Curie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(15)00146-5DOI Listing
September 2015

Who is the best hematopoietic stem-cell donor for a male patient with acute leukemia?

Transplantation 2014 Sep;98(5):569-77

1 Center for Allogeneic Stem Cell Transplantation and Division of Therapeutic Immunology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden. 2 Department of Haematology, Hôpital Saint Antoine, Paris, France. 3 Department of Bone Marrow Transplantation, Essen, University Hospital, Essen, Germany. 4 Medizinische Klinik m. S. Hämatologie/Onkologie, Charité Universitätsmedizin, Berlin, Germany. 5 Medizinische Klinik und Poliklinik I, Universitätsklinikum Dresden, Dresden, Germany. 6 CHU Bordeaux, Hôpital Haut-leveque, Pessac, France. 7 Division of Hematology, Oncology and Hemostasiology, University Hospital Leipzig, Leipzig, Germany. 8 Service Hématologie Greffe de Moelle, Centre Pierre et Marie Curie, Alger, Algeria. 9 Department of Hematology and BMT, Silesian Medical Academy, Katowice, Poland. 10 Department of Hematology/Oncology, Hannover Medical University, Hannover, Germany. 11 Department of Hematology - BMT, Hôpital St. Louis, Paris, France. 12 Department of Hematology/Oncology, University of Münster, Münster, Germany. 13 Division of Hematology, Helsinki University Central Hospital, Helsinki, Finland. 14 Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom. 15 Address correspondence to: Olle Ringdén, M.D., Ph.D., Karolinska Institutet, Division of Therapeutic Immunology, Karolinska University Hospital Huddinge, F79, SE-141 86 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/TP.0000000000000102DOI Listing
September 2014

Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: long-term follow-up of a randomized study.

Biol Blood Marrow Transplant 2014 Jan 17;20(1):135-8. Epub 2013 Oct 17.

Centre for Allogeneic Stem Cell Transplantation, Departments of Clinical Immunology and Medicine, Karolinska Hospital, Huddinge University Hospital, Huddinge, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.10.014DOI Listing
January 2014

Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation.

J Clin Oncol 2013 Oct 26;31(28):3549-56. Epub 2013 Aug 26.

Arnon Nagler and Avichai Shimoni, Chaim Sheba Medical Center, Tel Hasomer, Israel; Vanderson Rocha, Churchill Hospital, Oxford University Hospitals, Oxford, United Kingdom; Myriam Labopin and Mohamad Mohty, Hôpital Saint-Antoine, Paris University; Gerard Socie, Hôpital St Louis, Paris; Mauricette Michallet, Hôpital Edouard Herriot, Lyon; Ibrahim Yakoub-Agha, University Hospital Lille, France; Ali Unal, Erciyes Medical School, Kayseri, Turkey; Tarek Ben Othman, Centre National de Greffe de Moelle, Tunis, Tunisia; Antonio Campos, Instituto Portugues de Oncologia do Porto, Porto, Portugal; Liisa Volin, Helsinki University Central Hospital, Helsinki, Finland; Xavier Poire, Cliniques Universitaires St Luc, Brussels, Belgium; Mahmoud Aljurf, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia; Tamás Masszi, St Istvan and St Laszlo Hospital, Budapest, Hungary; Henrik Sengelov, National University Hospital, Copenhagen, Denmark; Jakob Passweg, University Hospital, Basel, Switzerland; and Hendrik Veelken, Leiden University Medical Center, Leiden, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.48.8114DOI Listing
October 2013

Growth factor-associated graft-versus-host disease and mortality 10 years after allogeneic bone marrow transplantation.

Br J Haematol 2012 Apr 2;157(2):220-9. Epub 2012 Feb 2.

Centre for Allogeneic Stem Cell Transplantation and Division of Clinical Immunology and Transfusion Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2012.09034.xDOI Listing
April 2012

Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation.

Blood 2010 Nov 17;116(22):4439-43. Epub 2010 Aug 17.

Service d'Hématologie Clinique, Centre Hospitalier Universitaire Hôtel Dieu, Université de Nantes, Centre d'Investigation Clinique en Cancerologie and Inserm U892, Nantes, France.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2010-02-26
Publisher Site
http://dx.doi.org/10.1182/blood-2010-02-266551DOI Listing
November 2010

[Allogenic stem cell transplantations in lymphoma patients].

Duodecim 2010 ;126(2):167-73

KYS:n sisätautien klinikka, PL 1777, 70211 Kuopio.

View Article

Download full-text PDF

Source
May 2010

Effect of fluconazole prophylaxis on the incidence of invasive candida infections and bacteraemias in patients with acute leukaemia.

Eur J Haematol 2008 May 23;80(5):391-6. Epub 2008 Jan 23.

Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2008.01041.xDOI Listing
May 2008

Retrospective evaluation of serum Epstein Barr virus DNA levels in 406 allogeneic stem cell transplant patients.

Haematologica 2007 Jun;92(6):819-25

Helsinki University Central Hospital, Department of Medicine, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.10751DOI Listing
June 2007

Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate.

J Clin Endocrinol Metab 2005 Jul 29;90(7):3877-85. Epub 2005 Mar 29.

Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital, FIN-00290 Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2004-2161DOI Listing
July 2005

Stress among allogeneic bone marrow transplantation patients.

Patient Educ Couns 2005 Jan;56(1):62-71

Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pec.2003.12.007DOI Listing
January 2005

Human herpesvirus 6 antigenaemia in allogeneic stem cell transplant recipients: impact on clinical course and association with other beta-herpesviruses.

Br J Haematol 2004 Sep;126(5):690-6

Department of Medicine, Helsinki University Central Hospital, PO Box 340, FIN-00029 HUS, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2004.05101.xDOI Listing
September 2004

Clinical and practical value of metaphase fluorescent in situ hybridization in follow-up after allogeneic stem cell transplantation in chronic myeloid leukemia.

Haematologica 2004 Feb;89(2):247-9

Departments of Pathology and Medical Genetics, Haartman Institute and Helsinki University Central Hospital, University of Helsinki, Finland.

View Article

Download full-text PDF

Source
February 2004

Lymphoproliferative disease after allogeneic stem cell transplantation--pre-emptive diagnosis by quantification of Epstein-Barr virus DNA in serum.

J Clin Virol 2003 Dec;28(3):275-83

Department of Virology, Haartman Institute, University of Helsinki and Helsinki University Central Hospital, FIN-00290 Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1386-6532(03)00022-2DOI Listing
December 2003

Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation.

Blood 2002 Sep;100(6):1977-83

Department of Medicine, Division of Hematology, Helsinki University Central Hospital, POB 340, FIN-00029 HUS, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2001-12-0159DOI Listing
September 2002